Pfizer and Moderna Engage in Patent Warfare Over COVID-19 Vaccines with Major Rulings
In the ongoing global patent disputes surrounding COVID-19 vaccines, Pfizer and BioNTech scored a significant victory this week against rival Moderna as two crucial decisions were rendered in the United States and Germany.
On Wednesday, the U.S. Patent and Trademark Office's Patent Trial and Appeal Board (PTAB) declared that all challenged claims in two of Moderna's vaccine patents are "unpatentable." This unexpected ruling follows Moderna's 2022 lawsuit against Pfizer and BioNTech for alleged infringement of three patents, including the two invalidated by the PTAB.
Moderna had contended that it was the pioneer in discovering the effectiveness of "using mRNA encoding for a full-length coronavirus spike protein in a lipid nanoparticle formulation" for generating neutralizing antibodies. The disputed patents, referred to as the "’600 and ’127 patents," were central to this claim.
While Pfizer and BioNTech successfully defended their stance on the invalidity of Moderna's patents, they also sought validation from the PTAB regarding the two patents. A spokesperson for BioNTech expressed satisfaction with the ruling, stating, "We believe in the value and strength of our innovative science and our intellectual property."
Moderna, however, expressed its intention to appeal the PTAB's decision to the U.S. Court of Appeals for the Federal Circuit, asserting that it "respectfully disagrees" with the outcome. Notably, this ruling does not impact Moderna's '574 patent, which remains part of the Massachusetts lawsuit.
In contrast, the week also brought setbacks for Pfizer and BioNTech. The Düsseldorf Regional Court in Germany ruled in favor of Moderna, determining that the companies infringed upon one of Moderna's European patents and should provide "appropriate compensation." A representative for BioNTech stated that they believe the ruling on EP949 is invalid and will appeal the decision.
The financial stakes are high in this patent landscape, with Pfizer, BioNTech, and Moderna having generated tens of billions in revenue from their COVID-19 vaccines. With numerous ongoing lawsuits across the globe, including the U.S., U.K., Europe, Canada, and Japan, the implications of these legal battles could be substantial for all parties involved.
2026-10-20
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
China National Salt Industry Corporation Advances 10,000 t/y Sodium Metal Expansion Project, Industry Leader Invests Nearly RMB 100 Million
-
When BASF Lets Agriculture Fly Solo: A Capital Repricing of Scale and Ambition
-
BASF’s Zhanjiang Integrated Site Commissions New Neopentyl Glycol (NPG) Unit
-
BASF and IFF Collaborate to Accelerate Innovation in Enzymes and Polymers
-
When Light Falls on Metal: The Industrial Romance of Xiaomi × BASF
-
DyStar Becomes a Wholly-Owned Subsidiary of Zhejiang Longsheng Group, Ending Longstanding Shareholder Disputes with a $5 Billion Deal
-
LBB Specialties to Distribute Imerys' Mineral Ingredients in North America
-
Evonik to Close Two German Plants, Further Cutting Europe’s High-Purity Silicon Tetrachloride Capacity
-
Evonik Reportedly Rejects BASF’s €10.3 Billion Takeover Bid as Too Low
-
OCI Exits TDI Business and Joins South Korean Semiconductor Materials Cluster on the Same Day
Recommend Reading
-
Procter & Gamble Posts Higher Profits on Strong Personal Care Sales and Recovery in China
-
Fracturing the Crown: BASF Antwerp’s 600-Job Cut and the Global Alarm
-
Wanhua Chemical's 240,000-ton/year Iron Phosphate Project Approved
-
Pharmaceutical State-Owned Enterprise Acquires Leading Pesticide Company for RMB 5.656 Billion, Betting on Synthetic Biology Industrialization
-
Henkel to Acquire Olaplex in $1.4 Billion Deal
-
Supply and Demand Game: Flexible Trends in the Chinese Melamine Market
-
Soda Ash Market Trends Remain Stable
-
Bullish Support, October Hydrogen Peroxide Prices Rise in China
-
Recent Domestic Maleic Anhydride Market Shows a Slight Decline
-
Lithium Carbonate Prices Strongly Rebound Amid Dual Supply-and-Demand Boost
- Hot Searches
- aniracetam supplement where to buy
- 4 methoxystyrene
- benzenesulfonic acid msds
- reta peptide price
- methylenediphenyl diisocyanate
- epoxy resin chemical formula
- dapagliflozin 5 mg tablet
- best place to buy research tirzepatide
- pottasium oxide
- purchase potassium cyanide
- calcium sulfate dihydrate
- retatrutide buy online